ArticleThe New England journal of medicine2020
Compassionate Use of Remdesivir in Covid-19. Reply.
Article in The New England journal of medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.Journal of infection and public health · 2020Pooled it
- Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants.Journal of virology · 2025Article
- Assessment of the liver with two-dimensional shear wave elastography following COVID-19 infection: A pilot study.Australasian journal of ultrasound in medicine · 2024Article
- A critical review on environmental presence of pharmaceutical drugs tested for the covid-19 treatment.Process safety and environmental protection : transactions of the Institution of Chemical Engineers, Part B · 2021Review
- Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19.The Eurasian journal of medicine · 2021Review
- Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience.Internal and emergency medicine · 2021Article
- SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.Advances in experimental medicine and biology · 2021Article
- That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19.Infectious diseases and therapy · 2020Review
- [Remdesivir for patients with COVID-19].Der Internist · 2020Article
- COVID-19 in Kidney Transplantation: Epidemiology, Management Considerations, and the Impact on Kidney Transplant Practice.Transplantation direct · 2020Review
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial.BioImpacts : BI · 2020Article
- Data on known anti-virals in combating CoVid-19.Bioinformation · 2020Article
Corrections and comments
- Comment on
- Comment on
- Comment on
- Comment on
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
32412709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.